Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515055-38-00

Acronym

PiT-023

Enrollment

300

Registered

2024-10-08

Start date

2025-02-13

Completion date

Unknown

Last updated

2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients undergoing TJR surgery.

Brief summary

The primary outcome is infection that requires reoperation within 12 months of TJR.

Interventions

DRUGPOVIDONE

DRUGCHLORHEXIDINE

DRUGVANCOMYCIN

DRUG-

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The primary outcome is infection that requires reoperation within 12 months of TJR.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026